HbA1c as a diagnostic tool for diabetes

International Congress Series

Volumn 1253, Issue C, 2003, Pages 19-26

  Balkau, Beverley ^a   Forhan, Anne ^a   Simon, Dominique ^a   Eschwège, Eveline ^a  

^a INSERM   (France)

Author keywords

Diabetes; Diagnosis; Glucose; HbA1c

Indexed keywords

EID: 84983321848     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(03)00540-5     Document Type: Article

References (23)

1. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997), Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997), 1183–1197.
2. Vinicor, F., When is diabetes diabetes?. JAMA 281 (1999), 1222–1224.
3. World Health Organisation Consultation, Definition, diagnosis and classification of diabetes mellitus and its complications: Part 1. Diagnosis and classification of diabetes mellitus, Report of a WHO Consultation, Geneva, Switzerland, 1999.
4. Orchard, T.J., From diagnosis and classification to complications and therapy. Diabetes Care 17 (1994), 326–328.
5. The DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch. Intern. Med. 161 (2001), 397–405.
6. McCance, D.R., Hanson, R.L., Charles, M.A., et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 308 (1994), 1323–1328.
7. Khaw, K.T., Wareham, N., Luben, R., et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 322 (2001), 15–18.
8. de Vegt, F., Dekker, J.M., Ruhe, H.G., et al. Hyperglycaemia is associated with all-cause and cardiovascular mortality in the Hoorn population: the Hoorn Study. Diabetologia 42 (1999), 926–931.
9. de Vegt, F., Dekker, J.M., Jager, A., Hienkens, E., Kostense, P.J., Stehouwer, C.D., Nijpels, G., Bouter, L.M., Heine, R.J., Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: the Hoorn Study. JAMA 285 (2001), 2109–2113.
10. Mooy, J.M., Grootenhuis, P.A., de Vries, H., Kostense, P.J., Popp-Snijders, C., Bouter, L.M., Heine, R.J., Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 39 (1996), 298–305.
11. Simon, D., Senan, C., Balkau, B., Saint-Paul, M., Thibult, N., Eschwege, E., Reproducibility of HbA1c in a healthy adult population: the Telecom Study. Diabetes Care 22 (1999), 1361–1363.
12. Simon, D., Senan, C., Garnier, P., Saint-Paul, M., Papoz, L., Epidemiological features of glycated haemoglobin A1c-distribution in a healthy population. The Telecom Study. Diabetologia 32 (1989), 864–869.
13. DECODE Study Group, Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317 (1998), 371–375.
14. Resnick, H.E., Harris, M.I., Brock, D.B., Harris, T.B., American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles. Results from the Third National Health and Nutrition Examination Survey. Diabetes Care 23 (2000), 176–180.
15. Peters, A.L., Davidson, M.B., Schriger, D.L., Hasselblad, V., A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis research group on the diagnosis of diabetes using glycated hemoglobin levels. JAMA 276 (1996), 1246–1252.
16. Davidson, M.B., Schriger, D.L., Peters, A.L., Lorber, B., Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. JAMA 281 (1999), 1203–1210.
17. Wang, W., Lee, E.T., Fabsitz, R., Welty, T.K., Howard, B.V., Using HbA(1c) to improve efficacy of the American Diabetes Association fasting plasma glucose criterion in screening for new type 2 diabetes in American Indians: the Strong Heart Study. Diabetes Care 25 (2002), 1365–1370.
18. Papoz, L., Favier, F., Sanchez, A., Clabe, A., Caillens, H., Boyer, M.C., Schwager, J.C., Is HbA1c appropriate for the screening of diabetes in general practice?. Diabetes Metab. 28 (2002), 72–77.
19. Barr, R.G., Nathan, D.M., Meigs, J.B., Singer, D.E., Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann. Intern. Med. 137 (2002), 263–272.
20. International Diabetes Federation (European Region), A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999. Diabetic Med. 16 (1999), 716–730.
21. Balkau, B., Forhan, A., Eschwege, E., Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 45 (2002), 1224–1230.
22. A.J.M. Bolton, C.D. Saudek, The need for standardisation of glycated haemoglobin measurements, Report on an International workshop held in Düsseldorf, Germany, January 17, 2002.
23. Wareham, N.J., Griffin, S.J., Should we screen for type 2 diabetes? Evaluation against national screening committee criteria. BMJ 322 (2001), 986–988.